July 28, 2022
Opioid/Substance Use Disorders
  • Allergan, a subsidiary of AbbVie, agreed to a $2 billion settlement with state and local governments to end thousands of lawsuits related to the marketing of its opioid Kadian. A federal court in Cleveland is working out details, such as the payout period and what document Allergan will need to publicly release. In December, Allergan reached a $200 million opioid settlement with New York State. (Articles here and here)